Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income	$ 10,747	$ 13,344
Adjustments to reconcile net income to net cash provided by operating activities:
Income from discontinued operations, net	0	(6,849)
Deferred income taxes	2,421	23,123
Depreciation, depletion and amortization	4,572	4,635
Equity in loss of joint ventures	3,773	1,282
Gain on sale of equipment and property	(9,343)	(657)
Stock-based compensation	1,241	206
Realized gain on available for sale investments	(297)	(591)
Net changes in operating assets and liabilities:
Accounts receivable	(377)	(355)
Deferred costs and other assets	(178)	(922)
Accounts payable and accrued liabilities	440	(1,252)
Income taxes payable and receivable	(340)	(17,335)
Other long-term liabilities	694	2,148
Net cash provided by operating activities of continuing operations	13,353	16,777
Net cash used in operating activities of discontinued operations	0	(1,756)
Net cash provided by operating activities	13,353	15,021
Cash flows from investing activities:
Investments in properties	(3,200)	(9,360)
Investments in joint ventures	(10,911)	(16,226)
Purchases of investments available for sale	(24,584)	(36,941)
Proceeds from sales of investments available for sale	57,240	89,260
Proceeds from the sale of assets	19,257	8,405
Cash held in escrow	(15,073)	(6,532)
Net cash provided by investing activities of continuing operations	22,729	28,606
Net cash provided by investing activities of discontinued operations	0	11,525
Net cash provided by investing activities	22,729	40,131
Cash flows from financing activities:
Distribution to noncontrolling interest	(713)	(1,086)
Repurchase of Company Stock	(15,687)	(7,714)
Exercise of employee stock options	0	347
Net cash used in financing activities of continuing operations	(16,400)	(8,453)
Net cash used in financing activities of discontinued operations	0	0
Net cash used in financing activities	(16,400)	(8,453)
Net increase in cash and cash equivalents	19,682	46,699
Cash and cash equivalents at beginning of year	26,607	22,547
Cash and cash equivalents at end of the period	$ 46,289	$ 66,246